Follow the 에스디바이오센서 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 에스디바이오센서 has logged 75 reports. Market capitalisation: €729.7bn. The latest transaction was disclosed on 24 March 2026 (Purchase). Among the most active insiders: 김석규. Every trade is free.
73
Insider Decl.
n/a
Thresholds
€2m
56 ops.
Buy Volume
n/a
12 ops.
Sell Volume
32Σ signal
Buys €2mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,462 of 29,057 companies
38.1
score / 100
Value
50
Quality
26
FCF yld41%
Earn yld-69%
EV/EBITDA·
ROE-27%
Gross mgn46%
Net mgn-72%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Cotizada en el mercado XKRX, 에스디바이오센서 es una empresa especializada en el sector de la salud y farmacéutico. Se enfoca en el desarrollo y la fabricación de dispositivos de diagnóstico médico.